PHARMACEUTICAL COMPOSITION FOR TREATING MIGRAINE

The present application relates to a method of treating migraine or cluster headache in a human patient, said method comprising administering subcutaneously composition comprising sumatriptan or its pharmaceutically acceptable salt, in an amount equivalent to 3 mg sumatriptan base.

Saved in:
Bibliographic Details
Main Authors Patil, Rajesh Ramesh, Raghuvanshi, Rajeev Singh, Gupta, Piyush, Prabhakara, Prabhu, Namboodiripad, Anil N
Format Patent
LanguageEnglish
Published 08.12.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present application relates to a method of treating migraine or cluster headache in a human patient, said method comprising administering subcutaneously composition comprising sumatriptan or its pharmaceutically acceptable salt, in an amount equivalent to 3 mg sumatriptan base.
Bibliography:Application Number: US202217833105